Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKiraz, Aslı Öztürk-
dc.identifier.issn0975-0959 (Online); 0301-1208 (Print)-
dc.description.abstractSimmondsin is a type of flavonoid it belongs to the group of flavan-3-ols (or simply flavanols (phenols). Phenolic compounds are known as antioxidants. In this study, we explain simmondsin’s antioxidant mechanism and investigate it to determine if it can be used as an anticancer therapeutic agent or not. Our results show that simmondsin is a very strong antioxidant that prefers hydrogen atom transfer (HAT) mechanism and can be benefited as an anticancer therapeutic agent. Hence, it can be used in cancer drugs to decrease the harmful effects of cancer cure.en_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJBB Vol.57(5) [October 2020]en_US
dc.subjectAnticancer therapeutic agenten_US
dc.subjectCytochrome P450en_US
dc.subjectMolecular dockingen_US
dc.titleTheoretical insight into the antioxidant, electronic and anticancer behaviour of simmondsinen_US
Appears in Collections:IJBB Vol.57(5) [October 2020]

Files in This Item:
File Description SizeFormat 
IJBB 57(5) 530-538.pdf610.24 kBAdobe PDFView/Open

Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.